7-Amino-3-(methoxymethyl)-3-cephem-4-carboxylic Acid

We are 7-Amino-3-(methoxymethyl)-3-cephem-4-carboxylic Acid CAS:24701-69-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:7-Amino-3-(methoxymethyl)-3-cephem-4-carboxylic Acid
CAS.NO:24701-69-7
Synonyms:7-AMCA; (6R,7R)-7-Amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
7-Amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
(6R-trans)-7-Amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
7-Amino-3-methoxymethyl-Δ3-cephem-4-carboxylic Acid
Molecular Formula:C9H12N2O4S
Molecular Weight:244.27
 
Physical and Chemical Properties:
Density:1.55
Boiling point:511.4ºC
Flash point:263.1ºC
 
Specification:
Appearance:White to yellowish powder
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:For the synthesis of Cefpodoxime

7-Amino-3-(methoxymethyl)-3-cephem-4-carboxylic Acid


Related News: Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.107099-99-0 In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.1-Bromo-2-(1-Methylethyl)Benzene Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.4-bromo-2,6-difenilpirimidina CAS:40734-24-5 Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.

Related Products
Product Name
ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate View Details
3-Cyanophenylboronic acid View Details
Tetrapropyl Ammonium Fluoride View Details
3-Chloro-4-methoxybenzoic Acid manufacturer o-cresol manufacturer 3-Chloropropyne manufacturer 1-[4-(3-chloropropoxy)-3-methoxyphenyl]ethanone manufacturer 2-(TRIFLUOROMETHYL)PHENYL ISOTHIOCYANATE manufacturer